Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Frontiers in Pharmacology|December 13, 2023
Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancerAlessandra I G Buma, Berber Piet, Rob Ter Heine, et al.
Clinical Pharmacokinetics|October 11, 2023
High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and BreakpointsAnouk M E Jansen, Rob Ter Heine, Paul E Verweij, et al.
Trials|December 12, 2023
A multicomponent intervention program to Prevent and Reduce AgItation and phySical rEstraint use in the ICU (PRAISE): study protocol for a multicenter, stepped-wedge, cluster randomized controlled trialRens W J Kooken, Bram Tilburgs, Rob Ter Heine, et al.
European Journal of Clinical Pharmacology|November 18, 2020
Normal fat mass cannot be reliably estimated in typical pharmacokinetic studiesRoeland E Wasmann, Elin M Svensson, Stein J Schalkwijk, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 27, 2018
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and OpportunitiesRon J Keizer, Rob Ter Heine, Adam Frymoyer, et al.
Case Reports in Oncology|November 13, 2024
Polyradiculitis as a Neurological Complication Associated with Adagrasib: A Case ReportKristofoor E Leeuwenberg, Rob Ter Heine, Johanna M M Gijtenbeek, et al.
British Journal of Clinical Pharmacology|September 2, 2022
Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept studyRené J Boosman, Nikki de Rouw, Alwin D R Huitema, et al.
Drug Safety|November 6, 2021
Mechanisms, Management and Prevention of Pemetrexed-Related ToxicityNikki de Rouw, Berber Piet, Hieronymus J Derijks, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 4, 2010
Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometryRobert S Jansen, Hilde Rosing, Wiete Kromdijk, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2023
Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulationAnouk M E Jansen, Rob Ter Heine, J P Donnelly, et al.
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Frontiers in Pharmacology|December 13, 2023
Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancerAlessandra I G Buma, Berber Piet, Rob Ter Heine, et al.
Clinical Pharmacokinetics|October 11, 2023
High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and BreakpointsAnouk M E Jansen, Rob Ter Heine, Paul E Verweij, et al.
Trials|December 12, 2023
A multicomponent intervention program to Prevent and Reduce AgItation and phySical rEstraint use in the ICU (PRAISE): study protocol for a multicenter, stepped-wedge, cluster randomized controlled trialRens W J Kooken, Bram Tilburgs, Rob Ter Heine, et al.
European Journal of Clinical Pharmacology|November 18, 2020
Normal fat mass cannot be reliably estimated in typical pharmacokinetic studiesRoeland E Wasmann, Elin M Svensson, Stein J Schalkwijk, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 27, 2018
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and OpportunitiesRon J Keizer, Rob Ter Heine, Adam Frymoyer, et al.
Case Reports in Oncology|November 13, 2024
Polyradiculitis as a Neurological Complication Associated with Adagrasib: A Case ReportKristofoor E Leeuwenberg, Rob Ter Heine, Johanna M M Gijtenbeek, et al.
British Journal of Clinical Pharmacology|September 2, 2022
Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept studyRené J Boosman, Nikki de Rouw, Alwin D R Huitema, et al.
Drug Safety|November 6, 2021
Mechanisms, Management and Prevention of Pemetrexed-Related ToxicityNikki de Rouw, Berber Piet, Hieronymus J Derijks, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 4, 2010
Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometryRobert S Jansen, Hilde Rosing, Wiete Kromdijk, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2023
Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulationAnouk M E Jansen, Rob Ter Heine, J P Donnelly, et al.
Pageof 16